Leukemia viruses, including bovine leukemia virus (BLV) and feline leukemia virus (FeLV), are retroviruses causing persistent infections in animals that can lead to leukemias, lymphomas, and immunosuppressive diseases. Accurate and timely diagnosis of these infections is essential for controlling disease spread, guiding veterinary care, and implementing eradication programs. Enzyme-linked immunosorbent assay (ELISA) kits targeting leukemia virus antigens or antibodies have become crucial diagnostic tools in clinical and research settings.
Principle of Leukemia Virus ELISA Kits
Leukemia virus ELISA kits typically operate on the sandwich or indirect ELISA principle, detecting viral antigens such as the p27 protein in FeLV or antibodies specific to BLV, notably targeting glycoprotein gp51 or capsid proteins. In the sandwich ELISA format, antibodies coated on microplates capture the antigen from the sample, and a secondary HRP-conjugated antibody enables quantification via colorimetric readout. In indirect ELISAs for antibody detection, recombinant viral proteins are immobilized to capture host antibodies produced in response to viral infection.
Applications
- Screening and confirming infection in veterinary clinics and diagnostic labs.
- Surveillance in livestock herds to prevent economic losses and control zoonotic risks.
- Monitoring vaccination and immune responses in animals.
- Supporting epidemiological studies on leukemia virus prevalence.
Leukemia virus ELISA kits provide a robust, sensitive, and specific method for detecting leukemia virus infections in both cattle and cats. Their ease of use and validated performance metrics make them indispensable for veterinary diagnostics and disease management.
